I don't have any doubt that bavi works and, ultimately, will benefit cancer patients everywhere. That is great. But, considering how long I've been in this thing and the amount of due diligence I've put in, I would like to make some money on my investment, too. That prospect was made 60% harder with the outstanding share count increasing by 60 million.
I, too, think we will hear about the end of dilution soon. When that happens, I will increase my position substantially. I'd rather buy more at $2.75 for the long haul knowing the ATM has been shut off until trial results are reported than at $1.62 wondering if and when it will ever happen. Just my opinion. Good luck.
Market Data 
Markets 
